Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United States and has a high rate of recurrence. Over 90 percent of bladder cancers are urothelial carcinomas, which originate in the innermost tissue layer of the bladder lining.
A study finds that the rate of death from opioids was 10 times lower in cancer patients than in the general population between 2006 and 2016
Over the past decade, immune checkpoint inhibitors have transformed cancer care for a variety of tumor types. This form of immunotherapy can lead to long-lasting responses in some patients; however, most patients’ cancers do not respond to this therapy, and those that initially respond may develop resistance.
Researchers present new data on cancer biology, treatment, screening and risk reduction at the AACR Virtual Annual Meeting I.
At the AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis.
Early detection of most cancers is an elusive and daunting task; nevertheless, it has remained a top priority for the cancer research community. Detecting cancer early has manifold advantages: It can increase a patient’s chances of successful treatment, prolong their survival, and substantially improve their quality of life.
Researchers from around the globe share insights into cancer and the coronavirus.
While the incidence of melanoma has been rising, the mortality rate has experienced a steep decline over the past few years. This is largely attributable to major advances in treatment during the past two decades, including the development of BRAF...
Testicular cancer forms when cancerous cells develop in one or both testicles. Almost all cases of the disease begin in the germ cells of the testicles, which are responsible for producing immature sperm. The two main types of testicular cancer are seminomas and nonseminomas, with nonseminomas typically being more aggressive.
A study shows that antibiotic use prior to starting immunotherapy for melanoma is associated with decreased survival and other cancer news of the week from the staff of Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More